Literature DB >> 656395

Two human trypsinogens. Purification, molecular properties, and N-terminal sequences.

O Guy, D Lombardo, D C Bartelt, J Amic, C Figarella.   

Abstract

The two human trypsinogens have been isolated from human pancreatic juice in a sufficient amount to study molecular and structural properties. The purification procedure included filtration on Sephadex G-100 followed by ion-exchange chromatography on DEAE-cellulose. The two trypsinogens represent 19% of total proteins of pancreatic juice. Trypsinogen 1, the major form, is present in a quantity twice that of trypsinogen 2, which is the most anionic protein in human pancreatic juice. The two proteins have partial immunological identity, close molecular weights (23 438 and 25 006 for trypsinogens 1 and 2, respectively) and similar amino acid compositions. The N-terminal sequences are the same for the first 9 residues: Ala-Pro-Phe-Asp4-Lys-Ile. The two proteins differ in the activation peptides released during the transformation to trypsins. Trypsinogen 2 liberates one octapeptide Ala-Pro-Phe-Asp4-Lys while trypsinogen 1 liberates two peptides, the same octapeptide and the pentapeptide (Asp)4-Lys.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656395     DOI: 10.1021/bi00602a014

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

Review 1.  Hereditary pancreatitis: new insights into acute and chronic pancreatitis.

Authors:  D C Whitcomb
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Expression and characterization of trypsinogen produced in the human male genital tract.

Authors:  A Paju; A Bjartell; W M Zhang; S Nordling; A Borgström; J Hansson; U H Stenman
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 3.  Biochemical models of hereditary pancreatitis.

Authors:  Miklós Sahin-Tóth
Journal:  Endocrinol Metab Clin North Am       Date:  2006-06       Impact factor: 4.741

4.  Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.

Authors:  S Tenner; C Fernandez-del Castillo; A Warshaw; W Steinberg; J Hermon-Taylor; J E Valenzuela; M Hariri; M Hughes; P A Banks
Journal:  Int J Pancreatol       Date:  1997-04

Review 5.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

Review 6.  Invertebrate trypsins: a review.

Authors:  Adriana Muhlia-Almazán; Arturo Sánchez-Paz; Fernando L García-Carreño
Journal:  J Comp Physiol B       Date:  2008-04-11       Impact factor: 2.200

7.  Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis.

Authors:  U Petersson; S Appelros; A Borgström
Journal:  Int J Pancreatol       Date:  1999-06

Review 8.  Insights into the genetic risk factors for the development of pancreatic disease.

Authors:  Zachary Zator; David C Whitcomb
Journal:  Therap Adv Gastroenterol       Date:  2017-01-05       Impact factor: 4.409

9.  Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen.

Authors:  András Szabó; Miklós Sahin-Tóth
Journal:  FEBS J       Date:  2012-10-30       Impact factor: 5.542

10.  Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics, and patients with pancreatitis and cancer of the pancreas.

Authors:  H Rinderknecht; I G Renner; C Carmack
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.